Phenylpropanolamine

What is Phenylpropanolamine

NOTE: This drug is discontinued in the US.

Phenylpropanolamine (PPA) is a non-prescription oral sympathomimetic agent structurally similar to pseudoephedrine; both are used for the treatment of nasal congestion.

PPA has less CNS stimulation, but a greater risk for cardiovascular side effects and risk of stroke compared to pseudoephedrine.

Phenylpropanolamine and all combination products containing this sympathomimetic component have been discontinued in the US by the FDA due to significant concerns for the risk of stroke and the inability to predict who is at risk.

This FDA action was based on the findings of the Yale Hemorrhagic Stroke Project.

Indications

  • allergic rhinitis
  • common cold
  • nasal congestion
  • obesity
  • urinary incontinence

For the treatment nasal congestion due to the allergic rhinitis, common cold, sinusitis, or other upper respiratory allergies

Side Effects

  1. angina
  2. anorexia
  3. anxiety
  4. arrhythmia exacerbation
  5. diaphoresis
  6. dizziness
  7. dysuria
  8. hallucinations
  9. headache
  10. hypertension
  11. insomnia
  12. interstitial nephritis
  13. intracranial bleeding
  14. irritability
  15. mydriasis
  16. myocardial infarction
  17. nausea
  18. palpitations
  19. premature atrial contractions (PACs)
  20. premature ventricular contractions (PVCs)
  21. psychosis
  22. renal failure (unspecified)
  23. restlessness
  24. rhabdomyolysis
  25. seizures
  26. sinus tachycardia
  27. stroke
  28. supraventricular tachycardia (SVT)
  29. tachypnea
  30. vomiting
  31. xerostomia

Monitoring Parameters

  • laboratory monitoring not necessary

Contraindications

  • acute myocardial infarction
  • angina
  • breast-feeding
  • cardiac arrhythmias
  • cardiac disease
  • cardiomyopathy
  • children
  • closed-angle glaucoma
  • coronary artery disease
  • diabetes mellitus
  • females
  • geriatric
  • heart failure
  • hypertension
  • hyperthyroidism
  • infants
  • MAOI therapy
  • pregnancy
  • prostatic hypertrophy
  • renal failure
  • renal impairment
  • substance abuse
  • tachycardia
  • urinary retention

Interactions

No information is available regarding drug interactions associated with Phenylpropanolamine

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856